VHL Antikörper
Kurzübersicht für VHL Antikörper (ABIN355105)
Target
Alle VHL Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Spezifität
- Specific for VHL protein. Species cross-reactivity: This antibody reacts with the human VHL protein. The sequence used for immunization is divergent from mouse protein and, therefore, it is unlikely that this antibody will react with mous
-
Aufreinigung
- Immunoaffinity purified
-
Immunogen
-
A synthetic peptide derived from the human VHL protein.
Type of Immunogen: Synthetic peptide
-
-
-
-
Applikationshinweise
-
Approved: WB
Usage: Suitable for use in Western Blot. -
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- Tris-citrate/phosphate buffer, 0.09 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
-
Short term: 4°C
Long term: Add glycerol (40-50%) -20°C.
-
-
- VHL (Von Hippel-Lindau Tumor Suppressor, E3 Ubiquitin Protein Ligase (VHL))
-
Andere Bezeichnung
- VHL / Von Hippel Lindau
-
Hintergrund
-
Name/Gene ID: VHL
Synonyms: VHL, Elongin binding protein, HRCA1, RCA1, VHL1, Von Hippel-Lindau syndrome, Protein G7, PVHL -
Gen-ID
- 7428
-
UniProt
- P40337
-
Pathways
- Tube Formation, Signaling Events mediated by VEGFR1 and VEGFR2, Ubiquitin Proteasome Pathway
Target
-